Catecholaminergic Polymorphic Ventricular Tachycardia

Progress in Cardiovascular Diseases

Volumn 51, Issue 1, 2008, Pages 23-30

  Liu, Nian ^a,b   Ruan, Yanfei ^a,b   Priori, Silvia G ^a,b  

^a IRCCS   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALSEQUESTRIN; NADOLOL; PROPRANOLOL; RYANODINE RECEPTOR;

ARTICLE; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; DEFIBRILLATOR; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG EFFICACY; ELECTROCARDIOGRAPHY; EMOTION; EXERCISE TEST; GENE IDENTIFICATION; GENETIC SCREENING; GENOTYPE; HEART ARREST; HEART VENTRICLE TACHYCARDIA; HUMAN; MOLECULAR GENETICS; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE;

CALSEQUESTRIN; CATECHOLAMINES; EMOTIONS; EXERCISE; HUMANS; MUTATION; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TACHYCARDIA, VENTRICULAR;

EID: 47049120519     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2007.10.005     Document Type: Article

References (37)

1. Reid D.S., Tynan M., Braidwood L., et al. Bidirectional tachycardia in a child. A study using His bundle electrography. Br Heart J 37 (1975) 339-344
2. Coumel P., Fidelle J., Lucet V., et al. Catecholamine-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases. Br Heart J 40 Suppl (1978) 28-37
3. Leenhardt A., Lucet V., Denjoy I., et al. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 91 (1995) 1512-1519
4. Priori S.G., Napolitano C., Tiso N., et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103 (2001) 196-200
5. Lahat H., Pras E., Olender T., et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 69 (2001) 1378-1384
6. Swan H., Piippo K., Viitasalo M., et al. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 34 (1999) 2035-2042
7. Priori S.G., Napolitano C., Memmi M., et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106 (2002) 69-74
8. Cerrone M., Colombi B., Bloise R., et al. Clinical and molecular characterization of a large cohort of patients affected with catecholaminergic polymorphic ventricular tachycardia. Circulation 110 Suppl II (2004) 552
9. Mohler P.J., Splawski I., Napolitano C., et al. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc Natl Acad Sci U S A 101 (2004) 9137-9142
10. Bhuiyan Z.A., Hamdan M.A., Shamsi E.T., et al. A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22. J Cardiovasc Electrophysiol 18 (2007) 1060-1066
11. Bauce B., Rampazzo A., Basso C., et al. Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers. J Am Coll Cardiol 40 (2002) 341-349
12. Tiso N., Stephan D.A., Nava A., et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10 (2001) 189-194
13. Kannankeril P.J., Mitchell B.M., Goonasekera S.A., et al. Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy. Proc Natl Acad Sci U S A 103 (2006) 12179-12184
14. 2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death. Circ Res 91 (2002) 218-225
15. Lehnart S.E., Wehrens X.H., Laitinen P.J., et al. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 109 (2004) 3208-3214
16. George C.H., Higgs G.V., and Lai F.A. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. Circ Res 93 (2003) 531-540
17. Cerrone M., Colombi B., Santoro M., et al. Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. Circ Res 96 (2005) e77-e82
18. Liu N., Colombi B., Memmi M., et al. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. Circ Res 99 (2006) 292-298
19. Song L., Alcalai R., Arad M., et al. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 117 (2007) 1814-1823
20. 2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 116 (2006) 2510-2520
21. 2+ waves. Eur Heart J 28 (2007) 1135-1142
22. Cerrone M., Noujaim S.F., Tolkacheva E.G., et al. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circ Res 101 (2007) 1039-1048
23. Postma A.V., Denjoy I., Kamblock J., et al. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet 42 (2005) 863-870
24. Aizawa Y., Komura S., Okada S., et al. Distinct U wave changes in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT). Int Heart J 47 (2006) 381-389
25. Monteforte N., Raytcheva-Buono E.V., Bloise R., et al. Electrocardiographic analysis of arrhythmias developing during exercise in patients with catecholaminergic polymorphic ventricular tachycardia: insights for mechanisms and site of origin. Circulation 116 (2007) II.492
26. di Barletta M.R., Viatchenko-Karpinski S., Nori A., et al. Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia. Circulation 114 (2006) 1012-1019
27. Postma A.V., Denjoy I., Hoorntje T.M., et al. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res 91 (2002) e21-e26
28. 2+ and trigger ventricular arrhythmias in mice. Circ Res 101 (2007) 617-626
29. Hasdemir C., Priori S.G., Overholt E., et al. Catecholaminergic polymorphic ventricular tachycardia, recurrent syncope, and implantable loop recorder. J Cardiovasc Electrophysiol 15 (2004) 729
30. Priori S.G., Napolitano C., Schwartz P.J., et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 292 (2004) 1341-1344
31. Zhang L., Benson D.W., Tristani-Firouzi M., et al. Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation 111 (2005) 2720-2726
32. Tester D.J., Arya P., Will M., et al. Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing. Heart Rhythm 3 (2006) 800-805
33. Sumitomo N., Harada K., Nagashima M., et al. Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 89 (2003) 66-70
34. Swan H., Laitinen P., Kontula K., et al. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations. J Cardiovasc Electrophysiol 16 (2005) 162-166
35. Rosso R., Kalman J.M., Rogowski O., et al. Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 4 (2007) 1149-1154
36. Facchini M., Crotti L., Ferranti C., et al. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 4 (2007) S48
37. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 (2006) e385-e484